Real-life performance of a COVID-19 rapid antigen detection test targeting the SARS-CoV-2 nucleoprotein for diagnosis of COVID-19 due to the Omicron variant

J Infect. 2022 May;84(5):e64-e66. doi: 10.1016/j.jinf.2022.02.022. Epub 2022 Feb 22.
No abstract available

Keywords: Covid-19; Field performance study; Omicron variant; Rapid antigen assay; Sars-CoV-2.

Publication types

  • Letter
  • Research Support, Non-U.S. Gov't

MeSH terms

  • COVID-19* / diagnosis
  • Humans
  • Immunologic Tests
  • Nucleoproteins
  • SARS-CoV-2*

Substances

  • Nucleoproteins

Supplementary concepts

  • SARS-CoV-2 variants